Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the efficacy of oxycodone/naloxone (OXN) for the
management of opioid-induced constipation (OIC) compared to oxycodone controlled-release
tablets (OXY) in subjects with moderate to severe low back pain and OIC who require
around-the-clock opioid therapy.